Letermovir莱莫维韦,917389-32-3

MCE 的所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务。

Letermovir

CAS No. : 917389-32-3

MCE 国际站：Letermovir

产品活性：Letermovir (AIC246) 是一种有效的 CMV 抑制剂，以病毒末端酶为靶目标，抑制其活性。

研究领域：Anti-infection

作用靶点：CMV

In Vitro: AIC246 has consistent antiviral efficacy, and there is remarkable selectivity of AIC246 for human cytomegaloviruses. AD169 mutant strains and designated rAIC246-1 and rAIC246-2 are highly resistant to Letermovir (AIC246), with EC₅₀s of 5.6 nM, 1.24 μM, 0.37 μM, respectively. Letermovir inhibits HCMV replication through a specific antiviral mechanism that involves the viral gene product UL56. Letermovir inhibits HCMV replication in cell culture by interfering with the proper cleavage/packaging of HCMV progeny DNA. Letermovir inhibits the current gold standard GCV by more than 400-fold with respect to EC₅₀s (mean, 4.5 nM versus 2 μM) and by more than 2,000-fold with respect to EC₉₀ values (mean, 6.1 nM versus 14.5 μM). Letermovir in conbination with anti-HCMV drugs causes additive antiviral effects, but there is no interaction between letermovir and anti-HIV drugs.

In Vivo: Letermovir (10-100 mg/kg/day, p.o.) leads to a dose-dependent reduction of the HCMV titer in transplanted cells compared to that of the placebo-treated control group using the mouse xenograft model.

相关产品：Drug Repurposing Compound Library Plus  |  FDA-Approved Drug Library Plus  |  FDA-Approved Drug Library Mini  |  Bioactive Compound Library Plus  |  Anti-Infection Compound Library  |  FDA-Approved Drug Library  |  Antiviral Compound Library  |  Drug Repurposing Compound Library  |  Anti-COVID-19 Compound Library  |  Orally Active Compound Library  |  FDA Approved & Pharmacopeial Drug Library  |  Drug-Induced Liver Injury (DILI) Compound Library  |  Rare Diseases Drug Library  |  Children’s Drug Library  |  EMA-Approved Drug Library  |  Ganciclovir  |  Floxuridine  |  Cidofovir  |  Xanthohumol  |  ML324  |  Maribavir  |  Brivudine  |  Braco-19 trihydrochloride  |  Valganciclovir hydrochloride  |  Fomivirsen sodium  |  Tricin  |  Artemisone  |  Ancitabine hydrochloride  |  FIT-039  |  Tomeglovir  |  SIRT1-IN-1  |  Soyasaponin II  |  Bisindolylmaleimide IV  |  Cyclopropavir  |  PMEDAP  |  B220  |  Enocitabine  |  Calcium trinatrium diethylenetriaminepentaacetic acid hydrate  |  CEF20  |  Cyclic HPMPC  |  Fiztasovimab

热门产品线：重组蛋白  |  化合物库  |  天然产物  |  荧光染料  |  PROTAC  |  同位素标记物

Trending products：Recombinant Proteins  |  Bioactive Screening Libraries  |  Natural Products  |  Dye Reagents  |  PROTAC  |  Isotope-Labeled Compounds